Search for: "Roxane Laboratories, Inc." Results 41 - 55 of 55
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Jul 2010, 11:03 am by FDABlog HPM
District Court for the District of Columbia’s April 2, 2010 order denying motions for preliminary injunction filed by Roxane Laboratories, Inc. and Apotex, Inc. concerning 180-day exclusivity for generic versions of Merck’s COZAAR and HYZAAR (i.e., losartan). [read post]
19 May 2010, 6:15 am
(Patent Docs) US: CAFC affirms claim construction and corresponding summary judgment of non-infringement: Scantibodies Laboratory, Inc. v. [read post]
13 May 2010, 4:44 pm by mcarzima@imediainc.com
  The companies, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Roxane Inc., Ben Venue Laboratories Inc. and Roxane Laboratories Inc., are all affiliates of German drug giant, Boehringer Ingelheim GmbH. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog)   Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on Mylan’s… [read post]
9 Apr 2010, 8:30 am by Lucas A. Ferrara, Esq.
These companies include Mylan Pharmaceuticals Inc., Roxane Laboratories Inc., and Torrent Pharmaceuticals Ltd. [read post]
10 Dec 2009, 1:52 pm by Qui Tam
Florida Attorney General Bill McCollum announced that the state will receive $8.5 million from a settlement with Roxane Laboratories, Inc., and its corporate affiliates. [read post]
1 Jun 2009, 5:43 am
The four companies involved are: Abbott Laboratories, Pharmacia Corp., Roxane Laboratories, Inc. and Warrick Phamaceuticals, Inc. [read post]
5 May 2009, 9:26 pm
.'s request for a jury trial in its suit against Roxane Laboratories Inc. [read post]
24 Apr 2007, 9:06 am
Davis (approved for publication).In a follow-up to an earlier opinion (discussed here on this blog), an intervenor in the case, Roxane Laboratories, Inc. [read post]
7 Apr 2007, 3:48 am
., sought and obtained a temporary restraining order (TRO), which was secured by a $3 million bond, enjoining the effectiveness of the approval by the Food and Drug Administration of an application by intervening defendant Roxane Laboratories, Inc. [read post]